Global Veterinary Renal Disease Market to Show Long-Term Expansion Trends from 2026–2035

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Biguanides Market By The End Of 2030?

The veterinary renal disease market has experienced robust expansion recently. The market is projected to expand from $16.59 billion in 2025 to $17.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.9%. Historically, this growth was influenced by factors such as an aging pet population, the delayed identification of renal disorders in animals, restricted access to advanced renal therapies, a rise in dehydration and infection cases, and a dependence on symptom-focused treatment methods.

The veterinary renal disease market is projected to expand significantly in the coming years, with its size expected to reach $22.42 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period is attributed to advancements in renal diagnostics and imaging, a rising adoption of preventive screening programs, the development of targeted renal medications, increasing availability of veterinary dialysis services, and growing awareness of chronic kidney disease management. Key trends anticipated over this period include the rising prevalence of chronic kidney disease in companion animals, an increasing focus on early diagnosis and routine renal screening, the growing adoption of long-term renal management therapies, the expansion of specialized renal treatment and dialysis services, and an emphasis on nutritional and supportive care for renal health.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15957&type=smp

Which Market Drivers Are Supporting The Expansion Of The Biguanides Market?

The growth of the veterinary renal disease market is anticipated to be propelled by the increasing trend of pet ownership. Veterinary renal disease refers to conditions that impact animal kidneys, leading to impaired function and potential symptoms such as elevated thirst, frequent urination, decreased appetite, and weight loss. While factors like longer pet lifespans, exposure to environmental toxins, dietary elements, and genetic predispositions contribute to the rise of veterinary renal disease itself, treatments for pets typically involve managing diet, administering medication, and providing fluid therapy to mitigate symptoms, slow disease progression, and enhance quality of life. For example, in April 2025, the Canadian Animal Health Institute, a trade association based in Canada, stated that in 2024, Canada was home to an estimated 7.2 million dogs and 8.2 million cats, highlighting that pets are a fundamental part of more than half of Canadian households. This clearly illustrates how increasing pet ownership is a key factor driving the expansion of the veterinary renal disease market.

Which Segment Classifications Shape The Biguanides Market?

The veterinary renal disease market covered in this report is segmented –

1) By Type: Diagnosis, Treatment

2) By Animal Type: Canine, Feline, Bovine, Equine, Other Animal Types

3) By Indication: Renal Failure, Chronic Kidney Disease (Ckd), Renal Cystitis, Kidney Stones, Nephritis, Other Indications

4) By Route Of Administration: Injectable, Oral

5) By Distribution Channel: Pharmacies, Pet Specialty Stores, E-Commerce, Other Distribution Channels

Subsegments:

1) By Diagnosis: Blood Tests, Urine Tests, Imaging, Biopsy

2) By Treatment: Medications, Dialysis, Kidney Transplantation, Fluid Therapy

How Are Trends Impacting The Veterinary Renal Disease Market?

Leading entities within the veterinary renal disease market are concentrating on advancing treatment and diagnostic technologies, encompassing novel diagnostic tests capable of identifying kidney injury even in the absence of obvious clinical signs. Such tests are designed to pinpoint subtle alterations in renal function or structure, thereby enabling prompt intervention to hinder the development of advanced renal dysfunction. Illustratively, in June 2023, IDEXX Laboratories Inc., a US-based entity specializing in veterinary products and services, unveiled the inaugural veterinary diagnostic test for identifying kidney injury in felines and canines. This particular test, named the IDEXX Cystatin B Test, aims to assist veterinarians in detecting kidney injury prior to the manifestation of changes in kidney function, consequently enhancing patient prognoses. The IDEXX Cystatin B Test is slated for inclusion in existing test panels that evaluate renal health, offering crucial information during an estimated two million patient consultations each year.

Which Companies Are Expanding Their Footprint In The Biguanides Market?

Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestlé Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Veterinary Transplant Services Inc., Kibow Biotech Inc.

Read the full veterinary renal disease market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-renal-disease-global-market-report

How Is The Biguanides Market Distributed Across Key Geographic Regions?

North America was the largest region in the veterinary renal disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biguanides Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15957&type=smp

Browse Through More Reports Similar to the Global Veterinary Renal Disease Market 2026, By The Business Research Company

Kidney Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Veterinary Infectious Disease Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Veterinary Healthcare Market 2026

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795